Our commitment in action
Through collaboration, we hope to overcome some of the biggest challenges facing global health.
Leading the Way in Drug Safety: IQVIA formed a novel alliance with the FDA Center for Biologics Evaluation and Research to monitor and evaluate the safety and effectiveness of various vaccines, blood products, and other biologics. For this important public health collaboration, IQVIA worked with the Observational Health Data Science and Informatics initiative and its world-class team of healthcare experts and unique data assets from Columbia University, Stanford University, Georgia Institute of Technology, University of California, Los Angeles and the Regenstrief Institute at the Indiana University School of Medicine to enhance the function and outputs of the initiative.
Fighting the Opioid Epidemic: IQVIA partnered with the American Medical Association’s Task Force to Reduce Opioid Abuse to help reverse the nation’s opioid epidemic and provided valuable insight into the ongoing efforts to combat this public health crisis. Our data and analyses helped illustrate the effects of legislation regarding opioids.
Bridging Oncology Gaps: IQVIA has established the Cancer Data Network – a network that reveals insights that can help our oncology community improve cancer care and patient outcomes, accelerate clinical research and enable innovative contracting. IQVIA is a founding member of DATA-CAN, the UK’s National Health Data Research Hub, and committed to developing the Cancer Data Network as part of the initiative.
Addressing Antibiotic Resistance: IQVIA collaborated with the U.S. Centers for Disease Control and Prevention and supported White House efforts to combat the overuse and misuse of antibiotics. Information and analysis identified significant regional and local variability in antibiotic use across the United States. The findings shed light on the driving factors behind the rising number of drug-resistant bacteria strains to better inform ongoing prevention efforts.
Assessing Disease Burden, Enabling Innovation: Tuberculosis is a major global public health challenge and India accounts for more than a quarter of these cases on an annual basis. As part of an effort funded by the Bill and Melinda Gates Foundation, IQVIA provided crucial information about tuberculosis managed by the private sector to enable understanding of the true disease burden in the country, and around the world. The work revealed significantly higher rates of tuberculosis than had been previously recognized, as well as prospective causes, which can inform preventative protocols going forward.
Malaria Access in Action: Most malaria-endemic countries lack the ability to monitor the relationship between disease burden and the national supply and quality of critically needed medicines. To address this challenge, we collaborated with the Medicines for Malaria Venture to consolidate data flow and enable the Uganda National Drug Authority to complete the development of a system for monitoring pharmaceutical use at a national level.
Enabling Alzheimer’s Insights: European Prevention of Alzheimer's Dementia (EPAD) is a public-private consortium designed to better understand the early stages of Alzheimer’s disease and prevent dementia before symptoms occur. EPAD selected IQVIA to oversee a longitudinal study of 6,000 non-identified patients that enables researchers to track development of Alzheimer’s disease symptoms.
